首页> 外文期刊>Analytical chemistry >Procedures for Analysis of Dried Plasma Using Microsampling Devices to Detect Sulfur Mustard-Albumin Adducts for Verification of Poisoning
【24h】

Procedures for Analysis of Dried Plasma Using Microsampling Devices to Detect Sulfur Mustard-Albumin Adducts for Verification of Poisoning

机译:使用微量采样设备检测硫芥菜-白蛋白加合物以验证中毒的干血浆分析程序

获取原文
获取原文并翻译 | 示例
       

摘要

Incorporation of the chemical warfare agent sulfur mustard (SM) produces a covalent adduct with human serum albumin (HSA) representing an established plasma biomarker of poisoning. Bioanalytical verification requires both plasma generation from whole blood and shipping to specialized laboratories following strict guidelines for complex packaging. These needs often push the infrastructural boundary in crisis regions and war zones. Therefore, we herein originally introduce different reliable bioanalytical procedures using filter paper as well as novel volumetric microsampling tools (Mitra devices and Noviplex DUO cards) to generate dried plasma samples not liable to the shipping constraints. In addition, the Noviplex device enables in-transit separation of plasma from whole blood without the need of a centrifuge. Plasma-loaded and dried devices were subjected to pronase treatment yielding the alkylated dipeptide hydroxyethylthioethyl-CysPro (HETE-CP) derived from the HSA-SM adduct that was detected by microbore liquid chromatography-electrospray ionization tandem-mass spectrometry (mu LC-ESI MS/MS). For all devices, samples exposed to SM yielded excellent linearity (0.025-50 mu M SM) and good precision (<= 13%) and fulfilled forensic quality criteria for ion ratios of qualifying and quantifying product ions. Stability of the HSA-SM adduct in dried and liquid plasma is shown under conditions of three climatic zones (temperate climate, hot and dry climate, and hot and humid climate) for at least 9 days simulating the period of delayed sample shipping. Our results originally document that dried plasma is appropriate for storage and shipping at ambient temperature and that novel microsampling tools are of essential benefit when targeting the HSA-SM adduct for verification analysis.
机译:化学战剂硫芥末(SM)的掺入会与人血清白蛋白(HSA)形成共价加合物,代表已确立的中毒血浆生物标志物。生物分析验证需要遵循严格的复杂包装指南,从全血中产生血浆,并运送到专门的实验室。这些需求通常会推高危机地区和战区的基础设施边界。因此,我们在这里最初引入了使用滤纸以及新型体积微量采样工具(Mitra设备和Noviplex DUO卡)的不同可靠的生物分析程序,以产生不受运输限制的干燥血浆样品。此外,Noviplex装置无需离心即可在血浆中从全血中进行血浆分离。对血浆加载并干燥的装置进行链霉蛋白酶处理,得到衍生自HSA-SM加合物的烷基化二肽羟乙基硫基乙基-CysPro(HETE-CP),通过微孔液相色谱-电喷雾串联质谱(μLC-ESI MS)进行检测/多发性硬化症)。对于所有设备,暴露于SM的样品均具有出色的线性(0.025-50μM SM)和良好的精密度(<= 13%),并满足鉴定和定量产物离子的离子比率的法医质量标准。在三个气候区(温带气候,炎热和干燥气候以及炎热和潮湿的气候)的条件下,显示了HSA-SM加合物在干燥和液体血浆中的稳定性,模拟了延迟样品运输的时间至少9天。我们的结果最初证明,干燥的血浆适合在环境温度下存储和运输,而当针对HSA-SM加合物进行验证分析时,新颖的微量采样工具具有必不可少的优势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号